BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33805352)

  • 1. National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Carcinoma In Situ of the Breast across Canadian Surgeons.
    Seguin R; Peiris L
    Curr Oncol; 2021 Mar; 28(2):1366-1375. PubMed ID: 33805352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of ductal carcinoma in situ in Australia in 1995.
    Shugg D; White VM; Kitchen PR; Pruden M; Collins JP; Hill DJ
    ANZ J Surg; 2002 Oct; 72(10):708-15. PubMed ID: 12534380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.
    DeSnyder SM; Hunt KK; Dong W; Smith BD; Moran MS; Chavez-MacGregor M; Shen Y; Kuerer HM; Lucci A
    Ann Surg Oncol; 2018 Oct; 25(10):2965-2974. PubMed ID: 29987598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
    Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
    World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
    Kruper L; Xu X; Henderson K; Bernstein L
    Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS).
    Price A; Schnabel F; Chun J; Kaplowitz E; Goodgal J; Guth A; Axelrod D; Shapiro R; Mema E; Moy L; Darvishian F; Roses D
    Breast J; 2020 May; 26(5):931-936. PubMed ID: 31957944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in low risk settings.
    Tasoulis MK; Hughes T; Babiera G; Chagpar AB
    Am J Surg; 2017 Sep; 214(3):489-494. PubMed ID: 28335989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands.
    Schreuder K; van Bommel ACM; de Ligt KM; Maduro JH; Vrancken Peeters MTFD; Mureau MAM; Siesling S
    Breast; 2017 Aug; 34():96-102. PubMed ID: 28552797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice.
    Montero-Luis A; Aristei C; Meattini I; Arenas M; Boersma L; Bourgier C; Coles C; Cutuli B; Falcinelli L; Kaidar-Person O; Leonardi MC; Offersen B; Marazzi F; Rivera S; Tagliaferri L; Tombolini V; Vidali C; Valentini V; Poortmans P
    Crit Rev Oncol Hematol; 2019 Jun; 138():207-213. PubMed ID: 31092377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
    Meijnen P; Gilhuijs KG; Rutgers EJ
    J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
    Rauch GM; Hobbs BP; Kuerer HM; Scoggins ME; Benveniste AP; Park YM; Caudle AS; Fox PS; Smith BD; Adrada BE; Krishnamurthy S; Yang WT
    Ann Surg Oncol; 2016 Feb; 23(2):482-9. PubMed ID: 26416712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
    Song HM; Styblo TM; Carlson GW; Losken A
    Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.